DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in DMK Pharmaceuticals Corp as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
DMK is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 3
- −26 vs. Q4 2023
- Shares held
- 68
- −500.4K (−100.0%) vs. Q4 2023
- Total value
- $4
- −$350.4K (−100.0%) vs. Q4 2023
- New holders
- 1
- 0 more added
- Sold out
- 27
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 3 | $4 |
| Q4 2023 | 29 | $350.4K |
| Q3 2023 | 25 | $178.7K |
| Q2 2023 | 22 | $276.4K |
| Q1 2023 | 47 | $3.20M |
| Q4 2022 | 48 | $2.16M |
| Q3 2022 | 43 | $2.55M |
| Q2 2022 | 45 | $6.44M |
| Q1 2022 | 46 | $7.38M |
| Q4 2021 | 49 | $8.58M |
| Q3 2021 | 53 | $14.6M |
| Q2 2021 | 51 | $17.8M |
| Q1 2021 | 53 | $11.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding DMK Pharmaceuticals Corp; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Point Advisors Inc. | 53 | $3 | 0.00% | 00.0% | Unchanged |
| Old Point Trust & Financial Services N A | 14 | $1 | 0.00% | +14 | New |
| Winch Advisory Services, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −106,209−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −103,493−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −71,098−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −65,203−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −38,735−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −33,990−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,185−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,237−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,059−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,558−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,562−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,335−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −561−100.0% | Sold out |
| Life Planning Partners, Inc | 0 | $0 | 0.00% | −304−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −214−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |